Edition:
India

People: Amneal Pharmaceuticals Inc (AMRX.N)

AMRX.N on New York Stock Exchange

3.98USD
25 Nov 2020
Change (% chg)

$-0.12 (-2.93%)
Prev Close
$4.10
Open
$4.10
Day's High
$4.11
Day's Low
$3.90
Volume
220,281
Avg. Vol
259,776
52-wk High
$5.78
52-wk Low
$2.40

Boyer, Andrew 

Mr. Andrew S. Boyer serves as Executive Vice President - Commercial Operations of the Company. Prior to joining Amneal, Mr. Boyer served as President & CEO of North America Generics, Teva Pharmaceutical Industries Ltd. from August 2016 to February 2018. Before that, Mr. Boyer was Senior Vice President of Sales and Marketing for the U.S. Generics Division at Allergan from September 2006 to August 2016. Mr. Boyer joined Allergan (then known as Watson Pharmaceuticals) in 1998 as Associate Director of Marketing in Generics. Before joining Allergan, Mr. Boyer served as National Accounts Manager for Lederle/American Cyanamid as well as Marketing Manager for Barr Laboratories. He serves as a Director of the Association for Accessible Medicines. Mr. Boyer received his bachelor’s degree in Business Administration and Management from State University of New York at Albany.

Basic Compensation

Total Annual Compensation, USD 660,084
Restricted Stock Award, USD 1,391,120
Long-Term Incentive Plans, USD --
All Other, USD 1,061,880
Fiscal Year Total, USD 3,113,080

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --